PRESENTATION

Q3 FY2025 — Presentation

Q3 FY2025PDF · 16 pages720 KB
Fiscal Year 2025, Third Quarter
January 31, 2025
EARNINGS CALL
PRESENTATION

-- 1 of 16 --

2
HORACIO ROZANSKI
Chairman, Chief Executive Officer & President
MATT CALDERONE
Executive Vice President, Chief Financial Officer
DUSTIN DARENSBOURG
Head of Investor Relations
CALL
PARTICIPANTS

-- 2 of 16 --

3
DISCLAIMER
Forward Looking Safe Harbor Statement
Certain statements contained in this presentation and in related comments by our management include “forward-looking statements” within the meaning of the Private Securities
Litigation Reform Act of 1995. Examples of forward-looking statements include information concerning Booz Allen’s preliminary financial results, financial outlook and guidance, including
forecasted revenue, Adjusted EBITDA, Diluted EPS, Adjusted Diluted EPS, future quarterly dividends, and future improvements in operating margins, as well as any other statement that
does not directly relate to any historical or current fact. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “could,” “should,” “forecasts,”
“expects,” “intends,” “plans,” “anticipates,” “projects,” “outlook,” “believes,” “estimates,” “predicts,” “potential,” “continue,” “preliminary,” or the negative of these terms or other
comparable terminology. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will
prove to have been correct.
These forward-looking statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our
actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these
forward-looking statements. A number of important factors could cause actual results to differ materially from those contained in or implied by these forward-looking statements,
including those factors discussed in our filings with the Securities and Exchange Commission (SEC), including our Annual Report on Form 10-K for the fiscal year ended March 31, 2024,
which can be found at the SEC’s website at www.sec.gov. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the
foregoing cautionary statements. All such statements speak only as of the date made and, except as required by law, we undertake no obligation to update or revise publicly any forward-
looking statements, whether as a result of new information, future events or otherwise.
Note Regarding Non-GAAP Financial Data Information
Booz Allen discloses Revenue, Excluding Billable Expenses, Adjusted Operating Income, Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, Adjusted EBITDA Margin on Revenue,
Excluding Billable Expenses, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow, Free Cash Flow Conversion, Net Leverage Ratio and organic revenue, which are not recognized
measurements under accounting principles generally accepted in the United States, or GAAP, and when analyzing Booz Allen’s performance or liquidity, as applicable, investors should (i)
evaluate each adjustment in our reconciliation of revenue to Revenue, Excluding Billable Expenses, operating income to Adjusted Operating Income, net income attributable to common
stockholders to Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses, Adjusted Net Income and Adjusted Diluted EPS,
and net cash provided by operating activities to Free Cash Flow and Free Cash Flow Conversion, and net debt to Net Leverage Ratio and the explanatory footnotes regarding those
adjustments, each as defined under GAAP, (ii) use Revenue, Excluding Billable Expenses, Adjusted Operating Income, Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, Adjusted
EBITDA Margin on Revenue, Excluding Billable Expenses, Adjusted Net Income, and Adjusted Diluted EPS in addition to, and not as an alternative to, revenue, operating income, net
income attributable to common stockholders or diluted EPS, as measures of operating results, each as defined under GAAP, (iii) use Free Cash Flow, Free Cash Flow Conversion, and Net
Leverage Ratio, in addition to, and not as an alternative to, net cash provided by operating activities as a measure of liquidity, each as defined under GAAP, and (iv) use Net Leverage Ratio
in addition to, and not as an alternative to, net debt as a measure of Booz Allen's debt leverage. The Appendix includes a reconciliation of Revenue, Excluding Billable Expenses, Adjusted
Operating Income, Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses, Adjusted Net Income, Adjusted Diluted EPS,
Free Cash Flow, Free Cash Flow Conversion, and Net Leverage Ratio to the most directly comparable financial measure calculated and presented in accordance with GAAP. Booz Allen
presents these supplemental performance measures because it believes that these measures provide investors and securities analysts with important supplemental information with
which to evaluate Booz Allen’s performance, long term earnings potential, or liquidity, as applicable, and to enable them to assess Booz Allen’s performance on the same basis as
management. These supplemental performance and liquidity measurements may vary from and may not be comparable to similarly titled measures by other companies in Booz Allen’s
industry. With respect to our expectations under “Financial Outlook”, reconciliation of Adjusted Diluted EPS guidance, Adjusted EBITDA, and Adjusted EBITDA Margin on Revenue to the
closest corresponding GAAP measure is not available without unreasonable efforts on a forward-looking basis due to our inability to predict our stock price, equity grants and dividend
declarations with respect to Adjusted Diluted EPS, and our net income, net interest and other expenses with respect to Adjusted EBITDA and Adjusted EBITDA Margin on Revenue, during
the course of fiscal 2025. With respect to Adjusted Diluted EPS guidance, projecting future stock price, equity grants and dividends to be declared would be necessary to accurately
calculate the difference between Adjusted Diluted EPS and GAAP EPS as a result of the effects of the two-class method and related possible dilution used in the calculation of EPS.
Consequently, any attempt to disclose such reconciliation would imply a degree of precision that could be confusing or misleading to investors. We expect the variability of the above
charges to have an unpredictable, and potentially significant, impact on our future GAAP financial results. For the same reason, a reconciliation of Adjusted EBITDA and Adjusted EBITDA
Margin on Revenue guidance for fiscal 2025, of Adjusted EBITDA guidance through fiscal 2025, and of inorganic revenue contributions through fiscal 2025 to the closest corresponding
GAAP measures are not available without unreasonable efforts on a forward-looking basis due to our inability to predict specific quantifications of the amounts that would be required to
reconcile such measures. Accordingly, Booz Allen is relying on the exception provided by Item 10(e)(1)(i)(B) of Regulation S-K to exclude these reconciliations.

-- 3 of 16 --

4
KEY FINANCIAL RESULTS
THIRD QUARTER FISCAL YEAR 2025 RESULTS
*NM = not meaningful.
(1) Comparisons are to prior fiscal year period.
(2) Reconciliations of Adjusted EBITDA and Adjusted EBITDA Margin on Revenue can be found on Slide 12. Net income margin was 6.4% and 8.2% and for the three and nine months ended December 31, 2024.
THIRD QUARTER (1) FISCAL YEAR-TO-DATE (12/31/24) (1)
Revenue $2.9 billion +13.5% $9.0 billion +14.1%
Revenue, Excluding Billable Expenses $2.0 billion +11.8% $6.2 billion +12.8%
Net Income $187 million +28.4% $742 million +55.4%
Adjusted EBITDA (2) $332 million +14.1% $998 million +12.3%
Adjusted EBITDA Margin on Revenue (2) 11.4% +0.9% 11.1% (1.8)%
Adjusted Net Income $198 million +7.4% $611 million +11.7%
Diluted EPS $1.45 +30.6% $5.73 +58.3%
Adjusted Diluted EPS $1.55 +9.9% $4.74 +13.7%
Net Cash Provided by Operating Activities $151 million (35.6)% $790 million NM*

-- 4 of 16 --

INVESTMENT THESIS
EXCEPTIONAL SHAREHOLDER VALUE CREATION
FY2023–FY2025 GOALS
Competitive
Edge at the
Mission-
Innovation
Intersection
ADJUSTED EBITDA
GROWTH TO $1.2–1.3B
Disciplined
Capital
Deployment
$2.0–3.5B
Organic
Revenue
5–8%
Strategic
Acquisitions &
Investments
Strong Mid 10%
Adjusted
EBITDA Margin
+ +

-- 5 of 16 --

6
KEY FINANCIAL RESULTS
THIRD QUARTER FISCAL YEAR 2025 RESULTS
THIRD QUARTER (1) FISCAL YEAR-TO-DATE (12/31/24) (1)
Revenue $2.9 billion +13.5% $9.0 billion +14.1%
Revenue, Excluding Billable Expenses $2.0 billion +11.8% $6.2 billion +12.8%
Net Income $187 million +28.4% $742 million +55.4%
Adjusted EBITDA (2) $332 million +14.1% $998 million +12.3%
Adjusted EBITDA Margin on Revenue2 11.4% +0.9% 11.1% (1.8)%
Adjusted Net Income $198 million +7.4% $611 million +11.7%
Diluted EPS $1.45 +30.6% $5.73 +58.3%
Adjusted Diluted EPS $1.55 +9.9% $4.74 +13.7%
Net Cash Provided by Operating Activities $151 million (35.6)% $790 million NM*
Page 4 intentionally repeated
*NM = not meaningful.
(1) Comparisons are to prior fiscal year period.
(2) Reconciliations of Adjusted EBITDA and Adjusted EBITDA Margin on Revenue can be found on Slide 12. Net income margin was 6.4% and 8.2% and for the three and nine months ended December 31, 2024.

-- 6 of 16 --

7
$22.0
HISTORICAL BACKLOG & BOOK-TO-BILL
(1) For information on the components of backlog, and the differences between backlog and remaining performance obligations, please see the Company's Form 10-Q for the fiscal quarter ended December 31, 2024. Totals may not sum due to
rounding.
BACKLOG ($ IN BILLIONS) (1)
BOOK-TO-BILL TRENDS
29.2 	28.6 31.8 	30.0 	31.2 	31.3
35.0 	34.3 	33.8 36.2
41.3 	39.4
$3.7 	$4.0 	$5.5 	$4.5 	$4.6 	$4.9 	$6.3 	$5.2 	$4.8 	$5.1 	$6.6 	$5.3
$9.9 	$10.0 	$10.4 	$10.1 	$9.5 	$9.0 	$10.1 	$9.2 	$9.5 	$10.1 	$10.3 	$9.3
$15.6 	$14.6 $16.0 	$15.4 	$17.1 	$17.3 $18.6 	$19.9 	$19.5 	$20.9
$24.3 $24.7
Funded 	Unfunded 	Priced Options
4Q22 	1Q23 	2Q23 	3Q23 	4Q23 	1Q24 	2Q24 	3Q24 	4Q24 	1Q25 	2Q25 	3Q25
1.66x
0.72x
2.40x
0.09x
1.47x
1.03x
2.41x
0.72x 	0.82x
1.72x
2.61x
0.37x
1.36x
1.21x 	1.32x 	1.22x
1.18x
1.24x 	1.29x 1.41x 1.25x
1.43x 	1.52x
1.41x
Quarterly Book-to-Bill 	LTM Book-to-Bill
4Q22 	1Q23 	2Q23 	3Q23 	4Q23 	1Q24 	2Q24 	3Q24 	4Q24 	1Q25 	2Q25 	3Q25
0.0x
1.0x
2.0x
3.0x

-- 7 of 16 --

8
CAPITAL ALLOCATION
DELIVERING STRONG CAPITAL RETURNS THROUGH EFFICIENT CAPITAL DEPLOYMENT
STRATEGY
– Our multi-year capital deployment plan follows a disciplined and opportunistic approach, subject to market conditions
– In Q3 FY2025, we deployed approximately $227.6 million:
– $65.5 million through quarterly dividends;
– $148.8 million through share repurchases(2);
– $9.3 million through strategic investments(3); and $4.0 million through acquisitions(3)
– The Board authorized a dividend increase of 7.8% to $0.55 per share payable on March 4, 2025 to stockholders of record on February 14, 2025
– Share repurchase authorization capacity is approximately $554.7 million as of December 31, 2024. The Board authorized on January 28, 2025 an
increase in total share repurchase authorization capacity of $500 million, bringing available capacity to approximately $1.0 billion.
HISTORICAL CAPITAL DEPLOYMENT ($ IN MILLIONS) (1)
QUARTERLY CAPITAL DEPLOYMENT ($ IN MILLIONS) (1)
164.2
200.2
251.5
300.3
227.6
$61.7 	$66.6 	$67.1 	$65.8 	$65.5
$94.5
$127.3 $89.5
$232.3
$148.8
$8.1
$6.2 	$94.9
$2.1
$13.3
Quarterly Dividends 	Share Repurchases 	M&A
3Q24 	4Q24 	1Q25 	2Q25 	3Q25
571.3
1,493.9
905.0
691.7
979.5
$181.1 	$209.1 	$235.7 	$253.4 	$265.1
$318.1 $419.3 $224.0
$415.0
$597.9	$72.2
$865.5
$445.3 	$23.3
$116.6
Quarterly Dividends 	Share Repurchases 	M&A
FY21 	FY22 	FY23 	FY24 	LTM
(3)
(1) Totals may not sum due to rounding.
(2) Includes share repurchases transacted but not settled and paid.
(3) Represents payments for acquisitions, net of cash acquired, and strategic investments.
(2) (3) (2)

-- 8 of 16 --

9
FINANCIAL OUTLOOK
FULL YEAR FISCAL 2025 GUIDANCE (1)
OPERATING PERFORMANCE Updated FY25
Guidance Prior FY25
Guidance
Revenue Growth 12.0% – 13.0% 11.0% – 13.0%
Adjusted EBITDA $1,310 – $1,330 million $1,300 – $1,330 million
Adjusted EBITDA Margin on Revenue ~11% ~11%
Adjusted Diluted EPS $6.25 – $6.40 $6.10 – $6.30
Net Cash Provided by Operating Activities $950 – $1,025 million $925 – $1,025 million
Free Cash Flow $850 – $925 million $825 – $925 million
(1) Reconciliations omitted in reliance on Item 10(e)(1)(i)(B) of Regulation S-K. See "Disclaimer".
(2) Inorganic revenue contributions are from PAR Government Systems Corporation, which was acquired in June 2024.
KEY ASSUMPTIONS Updated FY25
Assumptions Prior FY25
Assumptions
Inorganic Revenue Contributions (2) $80 – $90 million $80 – $90 million
Adjusted Effective Tax Rate 23% – 24% 23% – 25%
Average Diluted Shares Outstanding 128 – 129 million 128 – 129 million
Interest Expense $175 – $185 million $175 – $185 million
Depreciation and Amortization ~$160 million ~$160 million
Cash Taxes Related to Section 174 ~$100 million ~$100 million
Capital Expenditures ~$100 million ~$100 million

-- 9 of 16 --

10
APPENDIX

-- 10 of 16 --

11
NON-GAAP FINANCIAL INFORMATION
• “Revenue, Excluding Billable Expenses” represents revenue less billable expenses. Booz Allen uses Revenue, Excluding Billable Expenses because it provides management
useful information about the Company’s operating performance by excluding the impact of costs that are not indicative of the level of productivity of its client staff
headcount and its overall direct labor, which management believes provides useful information to its investors about its core operations.
• “Adjusted Operating Income” represents operating income before change in provision for claimed costs for historical rate years, acquisition and divestiture costs, financing
transaction costs, significant acquisition amortization, the reserve associated with the U.S. Department of Justice investigation disclosed in Note 20, “Commitments and
Contingencies,” in the Annual Report on Form 10-K for the fiscal year ended March 31, 2024, and insurance recoveries related to the Company’s fiscal 2024 settlement
disclosed in Note 20, “Commitments and Contingencies,” in the Annual Report on Form 10-K for the fiscal year ended March 31, 2024. Booz Allen prepares Adjusted
Operating Income to eliminate the impact of items it does not consider indicative of ongoing operating performance due to their inherent unusual, extraordinary or non-
recurring nature or because they result from an event of a similar nature.
• “Adjusted EBITDA” represents net income (loss) attributable to common stockholders before income taxes, net interest and other expense and depreciation and
amortization and before certain other items, including the change in provision for claimed costs for historical rate years, acquisition and divestiture costs, financing
transaction costs, the reserve associated with the U.S. Department of Justice investigation disclosed in Note 20, “Commitments and Contingencies,” in the Annual Report on
Form 10-K for the fiscal year ended March 31, 2024, insurance recoveries related to the Company’s fiscal 2024 settlement disclosed in Note 20, “Commitments and
Contingencies,” in the Annual Report on Form 10-K for the fiscal year ended March 31, 2024, and DC tax assessment adjustment. “Adjusted EBITDA Margin on Revenue” is
calculated as Adjusted EBITDA divided by revenue. “Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses” is calculated as Adjusted EBITDA divided by Revenue,
Excluding Billable Expenses. Booz Allen prepares Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, and Adjusted EBITDA Margin on Revenue, Excluding Billable
Expenses to eliminate the impact of items it does not consider indicative of ongoing operating performance due to their inherent unusual, extraordinary or non-recurring
nature or because they result from an event of a similar nature.
• “Adjusted Net Income” represents net income before: (i) change in provision for claimed costs for historical rate years, (ii) acquisition and divestiture costs, (iii) financing
transaction costs, (iv) significant acquisition amortization, (v) the reserve associated with the U.S. Department of Justice investigation disclosed in Note 20 to the
Consolidated Financial Statements in the Company's Form 10-K for the fiscal year ended March 31, 2024, (vi) insurance recoveries related to the Company’s fiscal 2024
settlement disclosed in Note 20, “Commitments and Contingencies,” in the Annual Report on Form 10-K for the fiscal year ended March 31, 2024, and (vii) amortization or
write-off of debt issuance costs and debt discount, in each case net of the tax effect where appropriate calculated using an assumed effective tax rate. Booz Allen prepares
Adjusted Net Income to eliminate the impact of items, net of tax, it does not consider indicative of ongoing operating performance due to their inherent unusual,
extraordinary or non-recurring nature or because they result from an event of a similar nature. Booz Allen views Adjusted Net Income as an important indicator of
performance consistent with the manner in which management measures and forecasts the Company's performance and the way in which management is incentivized to
perform.
• “Adjusted Diluted EPS” represents diluted EPS calculated using Adjusted Net Income as opposed to net income. Additionally, Adjusted Diluted EPS does not contemplate any
adjustments to net income as required under the two-class method as disclosed in the footnotes to the consolidated financial statements of the Company's Form 10-K for
the fiscal year ended March 31, 2024.
• "Free Cash Flow" represents the net cash generated from operating activities less the impact of purchases of property, equipment and software. "Free Cash Flow
Conversion" is calculated as Free Cash Flow divided by Adjusted Net Income.
• "Adjusted Effective Tax Rate" represents income tax expense (benefit) excluding the income tax effects of adjustments to net income, divided by adjusted earnings before
income tax expense.
• "Net Leverage Ratio" is calculated as net debt (total debt less cash) divided by Adjusted EBITDA over the prior twelve months.
• "Organic Revenue" and "Organic Revenue Growth" represents growth in consolidated revenue adjusted for revenue from acquisitions and divestitures.

-- 11 of 16 --

12
NON-GAAP FINANCIAL INFORMATION (Unaudited)
Three Months Ended
December 31, Nine Months Ended
December 31,
(In thousands, except share and per share data) 2024 2023 2024 2023
Revenue, Excluding Billable Expenses
Revenue $ 2,917,190 $ 2,569,801 $ 9,005,373 $ 7,890,569
Less: Billable expenses 938,534 799,896 2,851,537 2,436,988
Revenue, Excluding Billable Expenses* $ 1,978,656 $ 1,769,905 $ 6,153,836 $ 5,453,581
Adjusted Operating Income
Operating Income $ 291,259 $ 247,558 $ 1,095,032 $ 748,965
Change in provision for claimed costs (a) — — (113,112) (18,345)
Acquisition and divestiture costs (b) 306 1,952 7,693 5,480
Financing transaction costs (c) — — — 820
Significant acquisition amortization (d) 13,386 13,597 39,396 40,301
Legal matter reserve (e) — — — 27,453
Insurance recoveries (f) — — (115,320) —
Adjusted Operating Income $ 304,951 $ 263,107 $ 913,689 $ 804,674
EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin on Revenue & Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses
Net income $ 186,950 $ 145,644 $ 742,295 $ 477,750
Income tax expense 61,446 61,740 233,814 156,291
Interest and other, net (g) 42,863 40,174 118,923 114,924
Depreciation and amortization 40,156 41,113 123,341 123,867
EBITDA 331,415 288,671 1,218,373 872,832
Change in provision for claimed costs (a) — — (113,112) (18,345)
Acquisition and divestiture costs (b) 306 1,952 7,693 5,480
Financing transaction costs (c) — — — 820
Legal matter reserve (e) — — — 27,453
Insurance recoveries (f) — — (115,320) —
Adjusted EBITDA $ 331,721 $ 290,623 $ 997,634 $ 888,240
Net income margin 6.4 % 5.7 % 8.2 % 6.1 %
Adjusted EBITDA Margin on Revenue 11.4 % 11.3 % 11.1 % 11.3 %
Adjusted EBITDA Margin on Revenue, Excluding Billable
Expenses 16.8 % 16.4 % 16.2 % 16.3 %
12
* Revenue, Excluding Billable Expenses includes $113.1 million and $18.3 million of revenue for the nine months ending December 31, 2024 and
2023 respectively, resulting from the reduction to our provision for claimed costs as noted below.

-- 12 of 16 --

13
NON-GAAP FINANCIAL INFORMATION (Unaudited)
Three Months Ended
December 31, Nine Months Ended
December 31,
(In thousands, except share and per share data) 2024 2023 2024 2023
Adjusted Net Income
Net income $ 186,950 $ 145,644 $ 742,295 $ 477,750
Change in provision for claimed costs (a) — — (113,112) (18,345)
Acquisition and divestiture costs (b) 306 1,952 7,693 5,480
Financing transaction costs (c) — — — 820
Significant acquisition amortization (d) 13,386 13,597 39,396 40,301
Legal matter reserve (e) — — — 27,453
Insurance recoveries (f) — — (115,320) —
Amortization or write-off of debt issuance costs and debt
discount 1,099 1,062 3,264 2,950
Adjustments for tax effect (h) (3,845) 22,048 46,301 10,094
Adjusted Net Income $ 197,896 $ 184,303 $ 610,517 $ 546,503
Adjusted Diluted Earnings Per Share
Weighted-average number of diluted shares outstanding 127,940,137 130,489,050 128,909,493 131,058,754
Diluted earnings per share $ 1.45 $ 1.11 $ 5.73 $ 3.62
Adjusted Net Income Per Diluted Share (i) $ 1.55 $ 1.41 $ 4.74 $ 4.17
Free Cash Flow
Net cash provided by operating activities 150,772 233,985 789,991 115,068
Less: Purchases of property, equipment and software (17,181) (23,096) (73,428) (50,532)
Free Cash Flow $ 133,591 $ 210,889 $ 716,563 $ 64,536
Operating cash flow conversion 81 % 161 % 106 % 24 %
Free cash flow conversion 68 % 114 % 117 % 12 %
13

-- 13 of 16 --

14
NON-GAAP FINANCIAL INFORMATION (Unaudited)
14
(a) Represents the reduction to our provision for claimed costs for years prior to fiscal 2025 recorded during the second quarters of fiscal 2025 and 2024,
which resulted in a corresponding increase to revenue, as a result of the Defense Contract Audit Agency's findings related to its audits of our claimed costs
for multiple fiscal years. See Note 15, “Commitments and Contingencies,”to the condensed consolidated financial statements in the Company's Form 10-Q
for the quarter ended December 31, 2024 for further information.
(b) Represents costs associated with the acquisition efforts of the Company related to transactions for which the Company has entered into a letter of
intent to acquire a controlling financial interest in the target entity. Transactions primarily include the acquisitions of EverWatch Corp. (“EverWatch”) in
fiscal 2023 and PAR Government Systems Corporation (“PGSC”) in fiscal 2025. See Note 5, “Acquisition, Goodwill, and Intangible Assets,” to the condensed
consolidated financial statements in the Company's Form 10-Q for the quarter ended December 31, 2024 for further information.
(c) Reflects expenses associated with debt financing activities incurred during the second quarter of fiscal 2024.
(d) Amortization expense associated with acquired intangibles from significant acquisitions.
(e) Reserve associated with the U.S. Department of Justice's investigation of the Company. See Note 20, “Commitments and Contingencies,” to the
consolidated financial statements contained within the Annual Report on Form 10-K for the fiscal year ended March 31, 2024 for further information.
(f) Reflects insurance recoveries from claims related to the Company’s fiscal 2024 settlement as described in Note 20, “Commitments and Contingencies,”
to the consolidated financial statements contained within the Annual Report on Form 10-K for the fiscal year ended March 31, 2024.
(g) Reflects the combination of Interest expense and Other income, net from the condensed consolidated statement of operations.
(h) Reflects the tax effect of adjustments at an assumed effective tax rate of 26%, which approximates the blended federal and state tax rates, and
consistently excludes the impact of other tax credits and incentive benefits realized. The tax effect of certain discrete items is calculated specifically and
may vary from the general 26% rate. The prior period tax effect also includes an adjustment related to the indirect effects of the application of Section 174
of the Tax Cuts and Jobs Act of 2017 ($26.0 million and $22.0 million for the three and nine months ended December 31, 2023, respectively).
(i) Excludes adjustments of approximately $1.1 million and $4.1 million of net earnings for the three and nine months ended December 31, 2024,
respectively, and approximately $1.2 million and $3.9 million of net earnings for the three and nine months ended December 31, 2023 respectively,
associated with the application of the two-class method for computing diluted earnings per share.

-- 14 of 16 --

15
NON-GAAP FINANCIAL INFORMATION (Unaudited)
(In thousands, except share and per share data) Three Months Ended
December 31, 2024 Three Months Ended
September 30, 2024 Three Months Ended
June 30, 2024 Three Months Ended
March 31, 2024
Net income $ 186,950 $ 390,112 $ 165,233 $ 127,955
Income tax expense 61,446 123,240 49,128 91,323
Interest and other, net (a) 42,863 35,257 40,803 45,161
Depreciation and amortization 40,156 42,056 41,129 40,335
EBITDA $ 331,415 $ 590,665 $ 296,293 $ 304,774
Change in provision for claimed costs (b) — (113,112) — —
Insurance recoveries (c) — (115,320) — —
Acquisition and divestiture costs (d) 306 1,717 5,670 2,100
DC tax assessment adjustment (e) — — — (20,050)
Adjusted EBITDA $ 331,721 $ 363,950 $ 301,963 $ 286,824
Last 12 months Adjusted EBITDA $ 1,284,458
Total Debt $ 3,373,715
Less: Cash 453,539
Net Debt $ 2,920,176
Net Leverage Ratio (h) 2.3
Three Months Ended
December 31, 2023 Three Months Ended
September 30, 2023 Three Months Ended
June 30, 2023 Three Months Ended
March 31, 2023
Net income (loss) attributable to common
stockholders $ 145,644 $ 170,718 $ 161,388 $ (68,422)
Income tax (benefit) expense 61,740 55,071 39,480 (6,552)
Interest and other, net (a) 40,174 41,200 33,550 31,992
Depreciation and amortization 41,113 40,907 41,847 44,284
EBITDA $ 288,671 $ 307,896 $ 276,265 $ 1,302
Change in provision for claimed costs (b) — (18,345) — —
Acquisition and divestiture costs (d) 1,952 260 3,268 4,148
Financing transaction costs (f) — 820 — —
Legal matter reserve (g) — — 27,453 226,000
Adjusted EBITDA $ 290,623 $ 290,631 $ 306,986 $ 231,450
Last 12 months Adjusted EBITDA $ 1,119,690
Total Debt $ 3,421,106
Less: Cash 601,813
Net Debt $ 2,819,293
Net Leverage Ratio (h) 2.5 15
(a) Reflects the combination of Interest expense and Other
income, net from the condensed consolidated statement
of operations.
(b) Represents the reduction to our provision for claimed
costs for years prior to fiscal 2025 recorded during the
second quarters of fiscal 2025 and 2024, which resulted in
a corresponding increase to revenue, as a result of the
Defense Contract Audit Agency's findings related to its
audits of our claimed costs for multiple fiscal years. See
Note 15, “Commitments and Contingencies,” to the
condensed consolidated financial statements in the
Company's Form 10-Q for the quarter ended December 31,
2024 for further information.
(c) Reflects insurance recoveries from claims related to the
Company’s fiscal 2024 settlement as described in Note 20,
“Commitments and Contingencies,” to the consolidated
financial statements contained within the Annual Report
on Form 10-K for the fiscal year ended March 31, 2024.
(d) Represents costs associated with the acquisition efforts
of the Company related to transactions for which the
Company has entered into a letter of intent to acquire a
controlling financial interest in the target entity.
Transactions primarily include the acquisitions of
EverWatch Corp. (“EverWatch”) in fiscal 2023 and PAR
Government Systems Corporation (“PGSC”) in fiscal 2025.
See Note 5, “Acquisition, Goodwill, and Intangible
Assets,”to the condensed consolidated financial
statements in the Company's Form 10-Q for the quarter
ended December 31, 2024 for further information.
(e) Reflects the impact (specifically the revenue from
recoverable expenses) of the Company's unfavorable
ruling from the District of Columbia Court of Appeals
related to contested tax assessments from the District of
Columbia Office of Tax and Revenue (“DC OTR”). See Note
13, “Income Taxes,” to the consolidated financial
statements contained within the Annual Report on Form
10-K for the fiscal year ended March 31, 2024 for further
information.
(f) Reflects expenses associated with debt financing
activities incurred during the second quarter of fiscal 2024.
(g) Reserve associated with the U.S. Department of
Justice's investigation of the Company. See Note 20,
“Commitments and Contingencies,” to the consolidated
financial statements contained within the Annual Report
on Form 10-K for the fiscal year ended March 31, 2024 for
further information.
(h) "Net Leverage Ratio" is calculated as net debt (total
debt less cash) divided by Adjusted EBITDA over the prior
twelve months.

-- 15 of 16 --

16
FINANCIAL RESULTS – KEY DRIVERS
Third Quarter Fiscal 2025 – Below is a summary of the key factors driving results for the fiscal 2025 third quarter ended December 31, 2024 as
compared to the prior year period:
• Revenue increased 13.5% to $2.9 billion and Revenue, Excluding Billable Expenses increased 11.8% to $2.0 billion. Revenue growth was
primarily driven by strong demand for our services and solutions as well as continued headcount growth and higher billable expenses.
• Operating income increased to $291.3 million from $247.6 million, and Adjusted Operating Income increased to $305.0 million from $263.1
million. The increase in operating income was primarily driven by the same drivers benefiting revenue growth as well as strong contract-
level performance coupled with ongoing cost management efforts. The increase in Adjusted Operating Income was driven by the same
factors impacting operating income.
• Net income increased to $187.0 million from $145.6 million, and Adjusted Net Income increased to $197.9 million from $184.3 million.
These changes were primarily driven by the same factors as operating income and Adjusted Operating Income. The increase in Adjusted Net
Income was primarily driven by the same factors as Adjusted Operating Income, but was partially offset by a higher Adjusted Effective Tax
Rate compared to the prior year, which is the result of one time tax benefits recognized in the prior year.
• EBITDA increased to $331.4 million from $288.7 million and Adjusted EBITDA increased to $331.7 million from $290.6 million. These
changes were due to the same factors as operating income and Adjusted Operating Income, respectively.
• Diluted EPS increased to $1.45 from $1.11 and Adjusted Diluted EPS increased to $1.55 from $1.41. The changes were primarily driven by
the same factors as net income and Adjusted Net Income, respectively, as well as a reduction in share count.
• Net cash provided by operating activities was $150.8 million for the quarter ended December 31, 2024, as compared to $234.0 million in the
prior year. Free Cash Flow was $133.6 million for the quarter ended December 31, 2024, as compared to $210.9 million in the prior year.
The change in operating cash was primarily impacted by timing of tax payments and other operating cash outflows.

-- 16 of 16 --